TC Biopharm Holdings PLC
13F holders, Q2 2024 (June 30)8holders +3
3new positions
1sold out
1famous investor
$0.82avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding TC Biopharm Holdings PLC in their 13F filings, up 3 from Q1 2024. 3 opened new positions and 1 sold out. The largest holders were Platform Technology Partners ($41K), Citadel Advisors ($18K) and Csenge Advisory Group ($10K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- TC Biopharm Holdings PLC
- CUSIP
- 87807D400
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $24K |
| Exits | 1 | $23K |
All 13F filers, Q1 2024 → Q2 2024: 31,137 shares bought and 20,465 shares sold, net +10,672 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Platform Technology Partners | 0.01% | — | 50,000 | $41K |
| Citadel Advisors | 0.00% | New | 22,528 | $18K |
| Csenge Advisory Group | 0.00% | Reduce -17.2% | 12,000 | $10K |
| Signaturefd, LLC | 0.00% | New | 5,957 | $5K |
| UBS Group AG | 0.00% | Add +617.1% | 2,101 | $2K |
| Rhumbline Advisers | 0.00% | New | 844 | $691 |
| Wells Fargo & Company | 0.00% | No change | 50 | $41 |
| Headlands Technologies LLC | 0.00% | Reduce -96.9% | 3 | $2 |
"% of holder's portfolio" is TC BIOPHARM HOLDINGS PLC's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC the manager owns.